Market Analysis

CROs' IT investments increase as they strive for market differentiation

Published in Drug Week, January 7th, 2005

Healthy operating results and the growing need to differentiate their capabilities to deliver on-time, high-quality trials will lead contract research organizations (CROs) to increase their IT investments, according to Life Science Insights, an IDC Company.

Life Science Insights expects CROs to increase their spending on IT at a compound annual growth rate (CAGR) of 6.4% over the 2003-2008 period, reaching $1.7 billion by 2008.

"Today, clinical trial sponsors are selecting CROs with the technological capabilities that enable them to increase efficiency, time to market, and provide earlier risk evaluation during the clinical trial phase," said Ellen...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Drug Week

Source: Drug Week (2005-01-07)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry